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Research
AbstrACt
Objectives To determine whether it is feasible to set 
up a national registry, linking routinely collected data 
from hospital information systems (HIS), to investigate 
the role of cardiovascular magnetic resonance (CMR) in 
patients who activate the primary percutaneous coronary 
intervention (PPCI) pathway.
Design Feasibility prospective cohort study, to establish 
whether: (1) consent can be implemented; (2) data 
linkage and extraction from multiple HIS can be achieved 
for >90% of consented patients; (3) local data can be 
successfully linked with hospital episode data (Hospital 
Episode Statistics, HES; Patient Episode Database for 
Wales, PEDW) for >90% of consented patients and (4) the 
proportion of patients activating the PPCI pathway who 
get a CMR scan is ≥10% in hospitals with dedicated CMR 
facilities.
Participants Patients from four 24/7 PPCI hospitals in 
England and Wales (two with and two without a dedicated 
CMR facility) who activated the PPCI pathway and 
underwent an emergency coronary angiogram.
results Consent was successfully implemented at all 
hospitals (consent rates ranged from 59% to 74%) and 
1670 participants were recruited. Data submission was 
variable: all hospitals submitted clinical data (for ≥82% 
of patients); only three hospitals submitted biochemistry 
data (for ≥98% of patients) and echocardiography data 
(for 34%–87% of patients); only one hospital submitted 
medications data (for 97% of patients). At the two CMR 
centres, 14% and 20% of patients received a CMR scan. 
Data submitted by hospitals were linked with HES and 
PEDW for 99% of all consented patients.
Conclusion We successfully consented patients but 
obtaining individual, opt-in consent would not be feasible 
for a national registry. Linkage of data from HIS with 
hospital episode data was feasible. However, data from HIS 
are not uniformly available/exportable and, in centres with 
a dedicated CMR facility, some referrals for CMR were for 
research rather than clinical purposes.
IntrODuCtIOn
The amount of data about ‘usual care’ 
provided by UK National Health Service 
(NHS) hospitals that is being collected and 
stored electronically in hospital information 
strengths and limitations of this study
 ► We established a successful collaboration among 
four hospitals and exceeded the recruitment target 
for the study.
 ► We identified the main challenges that influence the 
feasibility of setting up the registry: (1) we could not 
identify all the eligible population; (2) we did not 
identify an optimal method of obtaining consent and 
(3) data from multiple hospital information system 
were not universally available.
 ► We did not have the time and resource to implement 
strategies to overcome these challenges, for 
example, testing out novel methods of identifying 
the eligible population and obtaining consent or 
obtaining the data.
 ► We did not include patients presenting with a 
broader diagnosis of acute coronary syndrome but 
not requiring emergency coronary angiography, 
who may also benefit from cardiovascular magnetic 
resonance.
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systems (HIS) is rapidly increasing. Previous studies have 
shown that it is possible to use multiple HIS to retrieve 
and compile these patient-level data into a research data-
base.1–3 We conducted a study to test the feasibility of 
setting up a large multicentre registry for patients who 
activate the primary percutaneous coronary intervention 
(PPCI) pathway (patients who have had an ST-elevation 
myocardial infarction (STEMI) and require an emer-
gency angiogram) by linking data from multiple HIS 
within several hospitals. If the registry was feasible, we 
had the longer-term aim to use registry data to evaluate 
the effectiveness and cost-effectiveness of cardiovascular 
magnetic resonance (CMR) imaging in this population. 
There are over 60 PCI centres in the UK offering PPCI 
(24/7 service), which would be eligible for inclusion in 
the registry.4 
CMR is a non-invasive imaging technique that assesses 
heart structure and function with high spatial and 
temporal resolution.5 The use of CMR has increased in 
recent years in all subgroups of patients with acute coro-
nary syndrome (ACS), including those who activate the 
PPCI pathway.6 However, there are no studies comparing 
health outcomes for patients who did or did not have 
CMR in patients who do activate the PPCI pathway. Recent 
systematic reviews highlighted the lack of high quality, 
adequately powered studies to establish the prognostic 
value of CMR findings in these patients.7 8 Similarly, few 
studies have assessed how CMR changes patient manage-
ment, despite the fact that cardiologists believe that 
CMR brings about important changes in management.9 
A well-designed registry would provide information on 
CMR use, CMR uptake over time, patients’ characteris-
tics associated with being referred for CMR, the impact of 
CMR on patient management and the prognostic value 
of CMR.
Our feasibility study had several objectives: (1) to imple-
ment consent and establish the likely patient consent 
rate for a future registry; (2) to determine whether data 
linkage and extraction from HIS could be carried out 
across multiple PPCI Hospitals in the UK; (3) to deter-
mine whether HIS data could be linked to hospital 
episode data (Hospital Episode Statistics, HES; Patient 
Episode Database for Wales, PEDW) and (4) to estimate 
the proportion of patients activating the PPCI pathway 
who get a CMR scan.
MethODs
study population and eligibility criteria
We approached all patients with ACS who activated the 
PPCI pathway at four NHS hospitals in England and 
Wales hosting 24/7 PPCI centres—the Bristol Heart Insti-
tute (University Hospitals Bristol NHS Foundation Trust), 
Leeds General Infirmary (Leeds Teaching Hospitals NHS 
Trust), Morriston Hospital (Abertawe Bro Morgannwg 
University Health Board, Swansea) and University 
Hospital of Wales (Cardiff and Vale University Local 
Health Board). Two of these (Bristol and Leeds) were 
defined as ‘CMR centres’, that is, hospitals that had a dedi-
cated CMR service; the other two (Swansea and Cardiff) 
were defined as ‘non-CMR centres’, that is, hospitals that 
did not have access to a dedicated CMR service. Patients 
were included if they were 18 years of age or older and 
underwent an emergency angiogram, defined as within 
2 hours of arrival at the hospital unless specified other-
wise by local protocols. Patients were excluded if they 
were prisoners or lacked mental capacity to consent.
study procedures
Eligible patients were identified manually (eg, by checking 
catheter laboratory records and handover sheets or by 
checking the local cardiology database or both). Patients 
were approached with information about the study once 
they had recovered sufficiently from their angiogram, 
before they were discharged from hospital. If this was not 
possible, patients were sent study information and consent 
forms by post. Postal consents were managed locally at 
each hospital. We requested participants’ consent to use 
all the information collected by the hospital in relation 
to the patients’ suspected myocardial infarction (index 
procedure) and all the information related to subsequent 
care and vital status in the first 12 months following the 
index procedure (from HES and PEDW).
Data collection
Each hospital was asked to provide the following data from 
local HIS for all recruited patients: (a) basic demography, 
(b) clinical characteristics on presentation at the index 
admission, periprocedural and postprocedural (PPCI) 
characteristics, (c) echocardiography and CMR reports, 
(d) biochemistry and (e) medications on discharge. Each 
hospital had the option of submitting a linked dataset (ie, 
link data from different HIS within a hospital) or submit 
unlinked data extracts from each of the above catego-
ries with a unique patient identifier in each extract. We 
initially established a data linkage model at Bristol (by 
liaising with the appropriate HIS managers at University 
Hospitals Bristol NHS Foundation Trust) and shared this 
with the other hospitals, although the decision about how 
to submit the data was left to each participating hospital.
For subsequent inpatient and outpatient activity in 
the 12 months following the index PPCI admission, we 
applied to NHS Digital to link our dataset with HES 
(inpatient, outpatient, accident and emergency and 
critical care data) for the hospitals in England and to 
NHS Wales Information Service (NWIS) for PEDW data 
(which collects equivalent information) for the hospitals 
in Wales. NHS Digital routinely links HES with Office 
for National Statistics (ONS) mortality data. Mortality 
data were unavailable through NWIS and the two Welsh 
hospitals provided these data for their patients. Follow-up 
data were used to characterise the frequency and dura-
tion of outpatient follow-up, unscheduled cardiac-related 
hospital readmissions and cardiac-related investigations/
procedures such as diagnostic angiography, repeat PCI or 
cardiac surgery.
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For patients who declined to consent or did not 
respond to an invitation to consent before study recruit-
ment ended, we collected a limited anonymised dataset 
to characterise the non-consenting patient population. 
Hospitals were provided with a look-up table for either 
English or Welsh postal codes so that the anonymised 
datasets could contain information on the Index of 
Multiple Deprivation (IMD) and Welsh Index of Multiple 
Deprivation (WIMD),10 which combines information 
from several domains (eg, income, employment, educa-
tion, health, etc) to produce an overall relative measure 
of deprivation.
Main outcome measures
The main prespecified outcome measures were feasi-
bility parameters (criteria that would have to be met 
before making the decision to progress to setting up a 
full registry): (1) patient consent implemented at all four 
hospitals; (2) data linkage and extraction from multiple 
local HIS achieved for >90% of consented patients at all 
four hospitals; (3) local data successfully linked with HES 
and PEDW for >90% of consented patients at all four 
hospitals and (4) CMR scan requested and carried out 
for ≥10% of patients activating the PPCI pathway in CMR 
hospitals.
Data analysis
Data were analysed using Stata/IC V.13. The analysis of 
feasibility outcomes was descriptive, with quantitative 
results expressed as percentages and 95% CIs and feasi-
bility assessed by comparing descriptive statistics against the 
corresponding criteria. We compared patients who did not 
consent (and for whom we received anonymised data) with 
those who did consent using standardised mean differences 
(SMDs).11 We used means and SDs, and medians and IQRs, 
for continuous variables and number (per cent) for cate-
gorical variables, to report the demographic variables and 
baseline characteristics of patients recruited from the four 
hospitals.
results
Implementing patient consent
The flow chart of patient recruitment and data collec-
tion is shown in figure 1. Consent was successfully imple-
mented at all hospitals between May 2013 and September 
2014, with consent rates ranging from 59% to 74%. Anony-
mised data for patients identified as eligible but who did 
not consent were available for over 80% of patients from 
three hospitals but only 50% of patients from one hospital. 
Table 1 shows the baseline characteristics of consented 
and non-consented patients. The IMD and WIMD were 
slightly higher among those who consented compared 
with those who did not (SMDs 0.31 and 0.27, respec-
tively). The percentage of patients who received PPCI was 
also higher among those who consented compared with 
those who did not (90% vs 65%, respectively, SMD, 0.70).
Table 2 shows the characteristics of participants by 
hospital. Participants from the four hospitals were similar 
with respect to demographics, comorbidities and previous 
cardiac interventions, although rates of hypertension 
were lower in patients from hospital B compared with 
patients from hospitals A, C and D (18% vs 41%–52%).
Data linkage and extraction across hospitals
Figure 2 shows the flowchart of data submitted from 
each hospital. One of the hospitals provided the data 
in a linked format; linkage was undertaken centrally 
for the other three hospitals with data linked on local 
hospital identifier. Clinical data were available for 93% 
of patients at all hospitals (range 82%–98%) (figure 2). 
The availability of echocardiography data was variable; 
one hospital was unable to submit any echocardiography 
data, one hospital submitted data for only 34% of patients 
and two submitted data for over 75% of patients. Echo-
cardiography data were submitted as ‘free-text’ reports, 
rather than coded data. Biochemistry data were available 
for ≥98% of patients from three hospitals; one hospital 
was unable to submit biochemistry data for any of its 
patients. Data about medications on discharge were avail-
able for 97% of patients from one hospital; the other 
three hospitals were unable to submit these data.
Data linkage with hes and PeDW
Identifiers and evidence of signed consent were submitted 
via secure portal to NHS Digital and NWIS; HES, ONS 
and PEDW data were received with our unique patient 
identifier embedded within each file for linkage. Data 
linkage with HES, PEDW and vital status was achieved 
for 99% of patients across all hospitals (n=1655/1670). 
The index PPCI was successfully identified for 1612/1670 
(97%) of the patients with linked data, with the admis-
sion date in HES/PEDW matching index event date 
(±1 day). Table 3 shows the cardiac-related events in the 
12 months following the index admission in the entire 
cohort. Overall, 55/1638 (3%) of patients died during 
follow-up (median age at death 73 years, IQR 66–82). 
Major adverse cardiovascular events rate in this cohort 
was 13% (219/1638).
Proportion of eligible population receiving CMr scan
A CMR scan was performed (within 10 weeks of the index 
event) for 20% and 14% of consented patients in CMR 
centres. CMR data from both hospitals were submitted as 
free-text reports; individual CMR parameters were diffi-
cult to extract from these. The baseline characteristics of 
patients who did and did not receive CMR are shown in 
table 4. Patients referred for CMR were slightly younger 
that those who did not have CMR. No other differences 
were noted.
DIsCussIOn
We tested the feasibility of setting up a large multicentre 
registry using routinely collected data from HIS to 
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evaluate the effectiveness and cost-effectiveness of CMR 
in patients with ACS who activate the PPCI pathway. Such 
a registry would document CMR activity in these patients 
and provide information on CMR use, uptake over time, 
patients’ characteristics associated with being referred for 
CMR, the impact of CMR on patient management and 
the prognostic value of CMR after PPCI. We found that 
recruitment and consenting of our patient population 
(using conventional consent), and linkage of local data 
with hospital episode/vital status data are feasible. More 
than 10% of patients (20% and 14% in hospitals A and B, 
respectively) had CMR within 10 weeks of the index event 
in hospitals with a dedicated CMR facility. However, we 
did not identify all eligible patients and could not obtain 
all of the requested data from all hospitals.
Identifying the eligible population
Patients who activated the PPCI pathway and received 
PCI were easy to identify from catheter laboratory data-
bases. Nevertheless, there were discrepancies between 
the number of PPCI patients identified as eligible and 
approached at each hospital and the numbers of PPCI 
cases reported to the British Cardiovascular Interven-
tion Society National Audit of PCIs4 for each hospital 
over the recruiting period, indicating that not all eligible 
patients were identified and approached. Patients who 
activated the PPCI pathway but had an emergency angio-
gram without PCI (ie, those with unobstructed coronary 
arteries) were more difficult to identify. There was no 
consistent terminology used to describe these patients in 
the databases; this created confusion and further manual 
checks, so many patients were missed.
Each hospital implemented its own methods for identi-
fying and consenting patients. Most eligible patients were 
identified manually (eg, by checking catheter laboratory 
records or by checking the local cardiology database, or 
both). One of the participating hospitals set up a database 
query (including the search terms ‘PPCI’, ‘QueryNot’ 
and ‘QuerProc’) in the local cardiology database to flag 
up eligible patients. However, the query was broad and 
relied on data input by staff in the catheter laboratory, 
which changed in ‘real time’. This made identification of 
some eligible patients difficult. For example, if a patient 
Figure 1 Flow chart of patient recruitment and data collection. *Number of patients with their index procedure identified in 
HES/PEDW (exact match on day or 1 day out) or inpatient or outpatient or accident and emergency data available in the year 
following the index procedure. Note that 1612/1670 (97%) of patient had their index procedure identified in HES/PEDW (exact 
match on day or 1 day out). CMR, cardiovascular magnetic resonance; HES/PEDW, Hospital Episode Statistics/Patient Episode 
Database for Wales.
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was originally marked as ‘PPCI’ but was subsequently 
found to have unobstructed coronary arteries on the 
angiogram, the ‘PPCI’ label was removed, but no further 
information was added, necessitating manual searches 
by local research staff to identify whether the patient was 
eligible or not. We did not explore the possibility of using 
Table 1 Baseline characteristics of consenting and non-consenting patients (for whom data were available)
Consenting patients (n=1649) Non-consenting patients (n=705) SMD*
Age (mean, SD)† 64 (12.7) 65.0 (14.2) 0.06
Male sex 1159/1516 (76%) 481/677 (71%) 0.12
Current smoker) 478/1473 (32%) 240/602 (40%) 0.16
IMD score (median; IQR)‡ 13.4 (7.7–25.8) 19.9 (10.4–34.9) 0.31
WIMD rank (median; IQR) § 891 (459–1370) 671 (268–1221) 0.27
Diabetes 231/1536 (15%) 134/645 (21%) 0.15
Hypertension 601/1455 (41%) 263/663 (40%) 0.03
Previous PCI 157/1552 (10%) 73/652 (11%) 0.04
Previous CABG 37/1540 (2%) 25/654 (4%) 0.09
Previous MI 193/1547 (12%) 101/650 (16%) 0.09
PPCI 1307/1452 (90%) 429/664 (65%) 0.70
No PPCI 145/1452 (10%) 235/664 (35%) 0.70
Length of stay (median; IQR) days¶ 3 (2–4) 2 (1–3.9) 0.13
Values are numbers (percentages) unless otherwise stated.
*SMDs can be interpreted as follows: values of 0.20 are ‘small’ in magnitude, those around 0.50 are ‘medium’ and those around or above 
0.80 are ‘large’.27
Missing data (consented patients, non-consented patients): †(8, 5), ‡(179, 15), §(92, 47), ¶(250, 78).
CABG, coronary artery bypass grafting; IMD, Index of Multiple Deprivation (low value reflects low level of multiple deprivation); MI, myocardial 
infarction; PCI, percutaneous coronary intervention; PPCI,  primary percutaneous coronary intervention; SMD, standardised mean difference; 
WIMD, Welsh Index of Multiple Deprivation (low value reflects high level of multiple deprivation).
Table 2 Baseline characteristics of participants by hospital
Hospital A (n=762) Hospital B (n=272) Hospital C (n=315) Hospital D (n=300)
Age (mean; SD)* 65.1 (12.7) 62.9 (12.5) 63.8 (12.4) 63.4 (13.0)
Male sex 512/655 (78%) 183/246 (74%) 238/315 (76%) 226/300 (75%)
Current smoker 191/660 (29%) 95/240 (40%) 95/300 (32%) 97/273 (36%)
IMD score (median; IQR)† 12.2 (7.1–21.7) 20.5 (10.1–39.2) – –
WIMD rank (median; IQR)‡ – – 817 (334–1478) 902 (553–1314.5)
Diabetes 91/700 (13%) 33/243 (14%) 70/310 (23%) 37/283 (13%)
Hypertension 275/663 (41%) 42/238 (18%) 143/282 (51%) 141/272 (52%)
Previous PCI 71/701 (10%) 35/242 (14%) 27/310 (9%) 24/299 (8%)
Previous CABG 21/704 (3%) 7/243 (3%) 5/308 (2%) 4/285 (1%)
Previous MI 88/707 (12%) 40/240 (17%) 33/312 (11%) 32/288 (11%)
PPCI 597/655 (91%) 220/243 (91%) 267/295 (91%) 223/259 (86%)
No PPCI 58/655 (9%) 23/243 (9%) 28/295 (9%) 36/259 (14%)
Length of stay (median; IQR) days§ 3 (2–4) 2 (1–3) 3 (1–4) 2 (1–4)
Values are numbers (percentages) unless otherwise stated. 
The total number of participants in each hospital are patients with any data available.
Missing data by hospital (hospital A, hospital B, hospital C, hospital D):
*Eight patients (1, 0, 0, 7).
†One hundred and seventy-nine patients (169, 10, not collected for hospitals C and D).
‡Data missing for 92 patients (not collected for hospitals A and B, 80, 12).
§Data missing for 250 patients (109, 2, 17, 122).
CABG, coronary artery bypass grafting; IMD, Index of Multiple Deprivation (low value reflects low level of multiple deprivation); MI, myocardial 
infarction; PCI, percutaneous coronary intervention; PPCI, primary percutaneous coronary intervention; SMD, standardised mean difference; 
WIMD, Welsh Index of Multiple Deprivation (low value reflects high level of multiple deprivation).
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automated tools such as Natural Language Processing to 
identify subgroups of our eligible population (eg, those 
with unobstructed coronary arteries at angiography) in 
local cardiology databases.
Implementing consent
We asked all participating hospitals to implement a system of 
written consent so that we could establish a consent rate and 
ensure that we had consent to obtain follow-up data from 
HES and PEDW. We met the feasibility objective of imple-
menting conventional prospective consent at all hospitals. 
Consent rates, ranging from 59% to 74%, were lower than 
we had anticipated for a study in which participants have no 
active involvement, suggesting that many patients identified 
as eligible were missed. PPCI patients are asleep immedi-
ately following the procedure, rarely confined to bed after 
the first 4–6 hours and many are discharged within 24 hours 
or transferred to referring hospitals. Some were admitted 
at the weekend, when research nurse cover was variable. We 
tried to capture missed patients through postal consent, but 
return rates were low and we did not have the resources 
to send reminders or make telephone calls. Competing 
studies were cited as an issue in some hospitals.
Written consent is resource intensive and, as our data 
illustrate, would not be feasible for identifying consecutive 
eligible patients for an extended registry. We explored alter-
native methods of obtaining consent as part of the feasibility 
study. We considered presumed consent but concluded that 
it would be unacceptable legally, given that in principle it 
is possible for patients to be asked to give consent for their 
data to be used for the study12; exemptions from this rule 
are only granted on a temporary basis or when consent is 
impossible, not just infeasible. We considered the option of 
requesting consent at the same time as requesting proce-
dural consent (eg, by adding a paragraph to the standard 
NHS form), but the emergency nature of emergency angi-
ography means that often only verbal assent is recorded by 
hand in the patient notes.
A possible solution would be to implement changes in 
NHS information technology (IT) administrative systems 
(ideally at the national level, maintained locally by NHS or 
research staff) to allow a record of verbal patient consent 
to be recorded within their electronic notes (eg, a ‘consent 
module’). The use of a system embedded within the NHS 
administrative systems could be applied more broadly to all 
registry projects, so that patients could be easily identified as 
having given/not given consent, having withdrawn consent 
or not having been asked for consent. It could also capture 
whether the patient consents to all data being used and if 
not, which data are specifically excluded from the consent. 
However, we are not clear whether verbal patient consent 
recorded in this way would comply with NHS Digital’s 
requirement for ‘explicit’ patient consent (the legal basis 
for accessing HES/ONS data).13
Patients and the public are broadly supportive of the use 
of electronic patient data for research,14–17 but there are 
concerns about potential breaches of privacy and misuse 
of health data.18 The public response to care data19 high-
lighted important challenges in terms of patient confi-
dence and trust in how electronic health records are used 
in medical research.20 Newer consent models have been 
Figure 2 Flow chart of data availability. Percentages for consenting and non-consenting patients are for those eligible and 
approached; anonymised data percentages are for total number of patients who did not consent; data available are for those 
consented. CMR, cardiovascular magnetic resonance.
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proposed, including a dynamic consent model, which 
would allow patients to control consent electronically 
through time and receive information about the uses 
of their data and up-to-date lay summaries of research 
projects that have used their data.21 Nevertheless, such 
a model would require investment in and maintenance 
of an e-infrastructure, which would be difficult in the 
current economic climate of the NHS. Others have called 
for more adaptive governance models depending on the 
particular circumstances of the proposed research.22 It 
was beyond the scope of this study to explore these possi-
bilities for obtaining consent.
Data linkage and extraction across hospitals
We did not meet the feasibility criterion for data linkage 
and extraction (achieved for >80% of patients at all four 
hospitals) from HIS for all the requested datasets. Only one 
hospital provided all of the requested datasets for >80% of 
eligible and consented patients. Some hospitals had entire 
datasets missing; medications on discharge were not avail-
able from hospitals B, C and D; information about echo-
cardiography tests were not available from hospital C and 
biochemistry data were not available from hospital D. There 
were several reasons for missing data. Some hospitals were 
unable to extract data from local stand-alone databases 
Table 3 Rates of death and cardiac-related events in the 12 months following the index admission in the entire cohort
No of events (%)
Person-years of 
observation
Events per 1000 person-years 
(95% CI)
Death 55/1638 (3) 1536.33 35.8 (27.0 to 46.6)
MI 74/1638 (5) 1376.04 53.8 (42.2 to 67.5)
Stroke 2/1638 (0.1) 1427.12 1.4 (0.02 to 5.1)
Repeat PCI 117/1638 (7) 1347.76 86.8 (71.8 to 104.0)
CABG 20/1638 (1) 1417.25 14.1 (8.6 to 21.8)
MACE (death, MI, revascularisation) 219/1638 (13) 1311.44 167.0 (145.6 to 190.6)
The denominator is 1638 since date of index admission was missing for 22 patients and Hospital Episode Statistics/Patient Episode Database 
for Wales data were unavailable for 10 patients.
CABG, coronary artery bypass grafting; MACE, major adverse cardiovascular events; MI, myocardial infarction; PCI, percutaneous coronary 
intervention.
Table 4 Baseline and CMR characteristics of patients who did and did not have CMR in hospitals A and B
Patients who had CMR (n=189)
Patients who did not have 
CMR (n=846) SMD*
Age (mean, SD)† 61.8 (11.7) 65.1 (12.8) 0.26
Male sex 121/154 (79%) 574/747 (77%) 0.04
Current smoker 52/168 (31%) 234/732 (32%) 0.02
IMD score (median; IQR)‡ 12.4 (7.5–23.5) 13.5 (7.8–26.3) 0.08
Diabetes 19/176 (11%) 105/767 (14%) 0.09
Hypertension 63/166 (38%) 254/735 (35%) 0.07
Previous PCI 18/176 (10%) 88/767 (11%) 0.04
Previous CABG 3/176 (2%) 25/771 (3%) 0.09
Previous MI 20/174 (11%) 108/773 (14%) 0.07
PPCI 140/154 (91%) 677/744 (91%) 0.003
No PPCI 14/154 (9%) 67/744 (9%) 0.003
Length of stay (median; IQR) days§ 2 (2–3) 3 (2–3) 0.11
Values are numbers (percentages) unless otherwise stated.
*SMDs can be interpreted as follows: values of 0.20 are ‘small’ in magnitude, those around 0.50 are ‘medium’ and those around or above 
0.80 are ‘large’.27
Missing data (patients who had CMR, patients who did not have CMR):
†Two patients (1, 1).
‡One hundred and eighty patients (43, 137).
§One hundred and twelve patients (32, 80).
CABG, coronary artery bypass grafting; CMR, cardiovascular magnetic resonance; IMD, Index of Multiple Deprivation (low value reflects 
low level of multiple deprivation); MI, myocardial infarction; PCI, percutaneous coronary intervention; PPCI, primary percutaneous coronary 
intervention; SMD, standardised mean difference.
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which were designed for a specific purpose, for example, 
logging biochemistry requests, storing and presenting test 
results. Such local databases were typically old and did not 
have an interface for data extraction; data would have had 
to be retrieved manually for each patient in turn, rather 
than submitting a ‘batch’ query. Obtaining data in this way 
was considered infeasible for a national registry (as well as 
time consuming) and hospitals were not requested to do 
so. Some data (eg, medications on discharge, bedside echo-
cardiography) were not recorded electronically and were 
only available in paper form (sometimes scanned but not 
coded/searchable). Non-bedside imaging tests were avail-
able electronically but as free-text reports rather than coded 
data and individual variables of interest were impossible to 
extract from these reports.
We had initially envisaged establishing a data linkage 
and extraction model in one hospital and using this to 
guide data extraction at the other hospitals. We envis-
aged that this model would be automated, with minimal 
IT support beyond the set-up phase. However, this was 
not possible because HIS for each dataset differed across 
hospitals and different hospitals provided different levels of 
start-up IT support for the research project. Data linkage 
requires expertise in several areas, including knowledge 
of the databases to be linked and skills in creating linkage 
programmes. This expertise was variable across hospitals 
and in-depth knowledge sometimes lacking; not surprising 
given the diversity of databases involved and the fact that 
some were old and being phased out.
The complexity of data retrieval from multiple HIS in 
secondary care in the NHS has been highlighted previ-
ously.1 The government’s vision for the NHS, outlined in 
the National Information Board’s complex Personalised 
Health and Care 2020 framework,23 is that it will be an 
entirely digital organisation by 2020. Although such a 
system, if properly implemented, should provide benefits 
for research as well as patient care, it is an ambitious goal 
given the current financial and operational pressures within 
NHS organisations. The earlier (and equally ambitious) 
National Programme for IT, which aimed to create a single 
electronic care record for patients, connect primary and 
secondary care IT systems, and provide a single IT platform 
for health professionals was dismantled, largely because IT 
companies could not provide solutions to match the ambi-
tion.24 Our experience from this study has highlighted 
the poor quality electronic infrastructure in hospitals and 
multitude of clinical databases that are not amenable to 
‘interoperability’ (ie, not needing extensive customisation 
or permission from the database vendor to provide data 
flow). Full interoperability for HIS therefore still appears a 
distant goal.25
CMr rates in hospitals with dedicated CMr facilities
Although more than 10% of patients in hospitals with 
a dedicated CMR facility were referred for CMR, many 
of these referrals (33% on hospital A) were for research 
rather than clinical purposes. It is not clear whether this 
reflects practice in other hospitals with dedicated CMR 
facilities. Referral for non-clinical reasons (unless the find-
ings are used to change clinical management) would dilute 
any observed effect of CMR on outcomes in an extended 
registry.
Data linkage with hes and PeDW
We met the feasibility objective with respect to linkage 
with HES and PEDW. Linkage was achieved for 99% of 
patients. We failed to achieve linkage for the remainder 
mainly because of missing identifiers (NHS numbers) in 
the datasets submitted from the Welsh Hospitals.
strengths and limitations
We established a successful collaboration among four 
hospitals and exceeded the recruitment target for the study 
of 1600 patients. We also identified the main challenges to 
establishing a prospective registry in the way we had envis-
aged: identifying the eligible population is difficult to do 
from HIS; the conventional consent model fails to capture 
a sizeable proportion of the eligible population and would 
be costly to implement; and, most importantly, the required 
local data from HIS are not uniformly available/exportable.
We are aware that CMR may benefit other groups of 
patients with ACS (eg, those with non-STEMI). However, 
we considered at the outset that it would be impossible 
to identify consecutive patients presenting with a broader 
diagnosis of ACS but not requiring emergency coronary 
angiography; being able to define and ascertain the entire 
eligible population is a key requirement of a high-quality 
registry. This was a particularly important consideration 
given that the proposed registry was based on the premise 
of linking information collected in the course of usual 
care, avoiding the time and cost burden of primary data 
collection.
Conclusions
We conclude that setting up a national registry by linking 
routinely collected data to investigate the role of CMR in 
patients with ACS who activate the PPCI pathway is not 
feasible in the current NHS IT environment. Registries 
(eg, national audits) that have managed to overcome 
issues with data collection and quality have achieved this 
through a lengthy process necessitating many iterations 
(and a feedback loop) before attaining any quality targets. 
This requires considerable investment, infrastructure and 
commitment at the national level, which would be diffi-
cult to achieve in a research setting. Although the impor-
tance of electronic health records for research has long 
been recognised and the wealth of information in the 
NHS puts the UK at a research advantage,26 this potential 
has yet to be fully realised. The rapidly changing IT envi-
ronment in the NHS will likely overcome the challenges 
of data extraction we experienced. Access to the data is 
likely to be the main challenge in the future; the lack of 
clarity over the safe and ethical secondary use of routinely 
collected data and increased concern about misuse of 
such data are the biggest barrier preventing better access 
to routine data for research.
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